We have once again been included in the annual Global Digital Health 100 list announced by The Journal of mHealth, which recognises the most innovative health technology companies from around the world.
The Global Digital Health 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered.
The diversity of this year’s list stands out immediately. With innovations targeting just about every corner of healthcare, the honouree companies offer technologies across a range of categories including, clinical solutions, wearable technologies, healthcare applications, medical devices, virtual reality and data analytics. These are all solutions and services that are transforming, or have the potential to transform, and disrupt the way in which healthcare is delivered.
Matthew Driver, Managing Editor of The Journal of mHealth, said
“One of the most profound differences identifiable in this year’s cohort is the number of technology providers who are delivering their solutions at scale. In past years, many of our featured technologies have been limited by their relatively small user groups, but as the healthcare technology market continues to mature we are now beginning to see more and more solutions that are successfully delivering these technology-driven modalities to much larger user bases.”
Certain areas in particular saw stand out growth during 2018, including: Technology-delivered mental health treatment; diabetes tech; data-led disease management; telehealth; and behavioural change therapies.
The Global Digital Health 100 represents 6 months of analysis by the editorial and advisory team at The Journal of mHealth, who considered the offerings and innovations from companies across the HealthTech ecosystem.
The judging criteria analysed 10 different quantitative and qualitative evaluation metrics including: disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and, industry integration. The selected 100 companies demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria ensure that companies are considered truly upon innovation, allowing start-up offerings to be compared alongside established and larger organisations.